Mucoadhesive Pharmacology: Latest Clinical Technology in Antiseptic Gels
- PMID: 38247746
- PMCID: PMC10815608
- DOI: 10.3390/gels10010023
Mucoadhesive Pharmacology: Latest Clinical Technology in Antiseptic Gels
Abstract
Chlorhexidine (CHX) is one of the most widely used antiseptics in the oral cavity due to its high antimicrobial potential. However, many authors have stated that the effect of CHX in nonsurgical periodontal therapy is hampered by its rapid elimination from the oral environment. The aim of this study was to determine the antibacterial efficacy of a new compound of chlorhexidine 0.20% + cymenol (CYM) 0.10% on a multispecies biofilm. For this, an in vitro study was designed using a multispecies biofilm model of Streptococcus mutans, Fusobacterium nucleatum, Prevotella intermedia, and Porphyromonas gingivalis. Quantification of the microbial viability of the biofilm was performed using 5-cyano-2,3-ditolyl tetrazolium-chloride (CTC) to calculate the percentage of survival, and the biofilms were observed using a a confocal laser scanning microscopy (CLSM). It was observed that the bactericidal activity of the CHX + cymenol bioadhesive gel was superior to that of the CHX bioadhesive gel, in addition to higher penetrability into the biofilm. Therefore, there was greater elimination of bacterial biofilm with the new compound of chlorhexidine 0.2% plus cymenol 0.1% in a bioadhesive gel form compared to the formulation with only chlorhexidine 0.2% in a bioadhesive gel form.
Keywords: antibacterial gels; antimicrobial gels; chlorhexidine; cymenol; periodontal application; substantivity.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures



Similar articles
-
Randomised-crossover clinical trial on the substantivity of a single application of a gel containing chlorhexidine and o-cymen-5-ol on the oral biofilm and saliva.BMC Oral Health. 2024 Oct 19;24(1):1247. doi: 10.1186/s12903-024-05042-7. BMC Oral Health. 2024. PMID: 39427170 Free PMC article. Clinical Trial.
-
Characterization and application of a flow system for in vitro multispecies oral biofilm formation.J Periodontal Res. 2014 Jun;49(3):323-32. doi: 10.1111/jre.12110. Epub 2013 Jul 1. J Periodontal Res. 2014. PMID: 23815431
-
[Efficacy of taurine haloamines and chlorhexidine against selected oral microbiome species].Med Dosw Mikrobiol. 2013;65(3):187-96. Med Dosw Mikrobiol. 2013. PMID: 24432558 Polish.
-
Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis.Int J Pharm. 2002 Mar 20;235(1-2):121-7. doi: 10.1016/s0378-5173(01)00974-7. Int J Pharm. 2002. PMID: 11879747
-
Antibacterial effect of silver nanoparticles mixed with calcium hydroxide or chlorhexidine on multispecies biofilms.Odontology. 2021 Oct;109(4):802-811. doi: 10.1007/s10266-021-00601-8. Epub 2021 May 28. Odontology. 2021. PMID: 34047872
Cited by
-
Evaluation of a new mouthwash formulated with Chlorhexidine and Cymenol after a scaling and root planing treatment in grade I and II periodontal patients.Med Oral Patol Oral Cir Bucal. 2024 Nov 1;29(6):e843-e849. doi: 10.4317/medoral.26818. Med Oral Patol Oral Cir Bucal. 2024. PMID: 39396137 Free PMC article. Clinical Trial.
-
Randomised-crossover clinical trial on the substantivity of a single application of a gel containing chlorhexidine and o-cymen-5-ol on the oral biofilm and saliva.BMC Oral Health. 2024 Oct 19;24(1):1247. doi: 10.1186/s12903-024-05042-7. BMC Oral Health. 2024. PMID: 39427170 Free PMC article. Clinical Trial.
References
-
- Lizambard M., Menu T., Fossart M., Bassand C., Agossa K., Huck O., Neut C., Siepmann F. In-situ forming implants for the treatment of periodontal diseases: Simultaneous controlled release of an antiseptic and an anti-inflammatory drug. Int. J. Pharm. 2019;572:118833. doi: 10.1016/j.ijpharm.2019.118833. - DOI - PubMed
-
- Aguilera F.R., Viñas M., Sierra J.M., Vinuesa T., RFernandez de Henestrosa A., Furmanczyk M., Trullàs C., Jourdan E., López-López J. Sub-stantivity of mouth-rinse formulations containing cetylpyridinium chloride and O-cymen-5-ol: A random-ized-crossover trial. BMC Oral Health. 2022;22:154–196. doi: 10.1186/s12903-022-02688-z. - DOI - PMC - PubMed
-
- Cresols M., Cresols I., Cresols M. Final report on the safety assessment of sodium p-Chloro-m-Cresol, p-Chloro-m-Cresol, Chlorothymol, Mixed Cresols, m-Cresol, o-Cresol, p-Cresol, Isopropyl Cresols, Thymol, o-Cymen-5-ol, and Carvacrol. Int. J. Toxicol. 2006;25:29–127. - PubMed
-
- Lim S.Y., Dafydd M., Ong J.J., Ord-McDermott L.A., Board-Davies E., Sands K., Williams D., Sloan A.J., Heard C.M. Mucoadhesive thin films for the simultaneous delivery of microbicide and anti-inflammatory drugs in the treatment of peri-odontal diseases. Int. J. Pharm. 2020;573:118860. doi: 10.1016/j.ijpharm.2019.118860. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases